MedTrace Logo

Post Market Usability Evaluation Of The PicoSure Pro Device

NCT05102617 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-01-09

No results posted yet for this study

Summary

The intended use of the PicoSure and PicoSure Pro devices used in this study is to treat additional patients with the new PicoSure Pro device and collect additional data on the devices.

Conditions

  • Wrinkle
  • Acne Scars
  • Benign Epidermal Pigmented Lesions
  • Benign Dermal Pigmented Lesions
  • Tattoo Removal

Interventions

DEVICE

PicoSure Pro Device

This device will be used for up to 4 treatments over the designated areas.

DEVICE

PicoSure Device

This device will be used for up to 4 treatments over the designated areas.

DRUG

Topical Cosmeceuticals

Topical cosmeceuticals, such as a hydrating serum or cream, will be applied on the designated area.

Sponsors & Collaborators

  • Cynosure, Inc.

    lead INDUSTRY

Principal Investigators

  • Jennifer Civiok · Director of Clinical Research

  • Sean Doherty · Cynosure, Inc.

  • Emil Tanghetti · Center for Dermatology and Laser Surgery

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-21
Primary Completion
2023-03-15
Completion
2023-03-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05102617 on ClinicalTrials.gov